首页>
外国专利>
8-O,n- and 8,21-di-o-acyl-3-piperazinyl-rifamycin S derivs. - with hypolipaemic activity, prepd. by acylation of non-acylated cpds. with a tri:alkyl-acetic acid deriv. e.g. pivaloyl chloride
8-O,n- and 8,21-di-o-acyl-3-piperazinyl-rifamycin S derivs. - with hypolipaemic activity, prepd. by acylation of non-acylated cpds. with a tri:alkyl-acetic acid deriv. e.g. pivaloyl chloride
8-O,N- or 8,21-diacyl- 3-(4-(2,6-dimethylbenzyl) -1-piperazinyl) rifamycin S derivs. of formula (I) and their salts are new: (where R is lower alkyl; R1 is tri(lower alkyl) methyl-carbonyl; and one of R2 and R3 is tri(lower alkyl)methyl-carbonyl and the other is H). 8,21-Di-O-pivaloyl- 3-(4-(2,4,6-trimethylbenzyl) -1-piperazinyl) rifamycin S (Ia) and 8-O,N-dipivaloyl-3 -(4-(2,4,6-trimethylbenzyl) -1-piperazinyl) rifamycin S (Ib) are specifically claimed. (I) are obtd. by reaction of corresponding non-acylated cpds. of formula (II) with an acylating agent capable of introducing a tri-(lower alkyl)methyl carbonyl gp. into the 8-position and into the 21-posn. or onto the ring amide N-atom, a resulting isomer mixt. being sepd. if desired.
展开▼
机译:8-O,N-或8,21-二酰基-3-(4-(2,6-二甲基苄基)-1-哌嗪基)利福霉素S衍生。式(I)的盐及其盐是新的:(其中R是低级烷基; R 1是三(低级烷基)甲基-羰基; R 2和R 3之一是三(低级烷基)甲基-羰基,另一个是H) 。 8,21-二-O-新戊酰基-3-(4-(2,4,6-三甲基苄基)-1-哌嗪基)利福霉素S(Ia)和8-O,N-二新戊酰基-3-(4-(2 (4,6-三甲基苄基)-1-哌嗪基)利福霉素S(Ib)被特别要求保护。 (I)肥胖。通过反应相应的未酰化的cpds。用能引入三(低级烷基)甲基羰基羰基的酰化剂制备式(Ⅱ)的化合物。进入8位和21位或在环酰胺N原子上,生成异构体混合物。被分隔如果需要的话。
展开▼